|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2013-03-27 |
|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1985-12-20 |
Non-interventional, prospective, multicenter study to evaluate treatment satisfaction, treatment preference, quality of life, and tolerability under treatment with Briumvi® for relapsing forms of multiple sclerosis (RMS) with active disease in daily clinical practice - Briumvi® - Real World Experience Study (BRILL Study)
100 项与 Neuraxpharm Pharmaceuticals S.L. 相关的临床结果
0 项与 Neuraxpharm Pharmaceuticals S.L. 相关的专利(医药)
100 项与 Neuraxpharm Pharmaceuticals S.L. 相关的药物交易
100 项与 Neuraxpharm Pharmaceuticals S.L. 相关的转化医学